CORELEASE EC Trademark

Trademark Overview

On Friday, January 5, 2024, a trademark application was filed for CORELEASE EC with the United States Patent and Trademark Office. The USPTO has given the CORELEASE EC trademark a serial number of 98344396. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, May 27, 2025. This trademark is owned by BPSI Holdings LLC. The CORELEASE EC trademark is filed in the Chemical Products category with the following description:

Excipients for use in the manufacture of pharmaceutical, nutritional supplement and veterinary preparations
corelease ec

General Information

Serial Number98344396
Word MarkCORELEASE EC
Filing DateFriday, January 5, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateTuesday, May 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkCORE LEASE EC; CO RELEASE ETHYLCELLULOSE
Goods and ServicesExcipients for use in the manufacture of pharmaceutical, nutritional supplement and veterinary preparations
NOT AVAILABLE"EC"

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, January 5, 2024
Primary Code001
First Use Anywhere DateFriday, March 28, 2025
First Use In Commerce DateFriday, March 28, 2025

Trademark Owner History

Party NameBPSI Holdings LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19803

Trademark Events

Event DateEvent Description
Friday, January 5, 2024NEW APPLICATION ENTERED
Tuesday, April 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 24, 2024ASSIGNED TO EXAMINER
Wednesday, July 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 10, 2024NON-FINAL ACTION E-MAILED
Wednesday, July 10, 2024NON-FINAL ACTION WRITTEN
Friday, October 4, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, October 4, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, January 10, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 10, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 10, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 12, 2025FINAL REFUSAL WRITTEN
Wednesday, February 12, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 12, 2025FINAL REFUSAL E-MAILED
Thursday, April 3, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, May 2, 2025USE AMENDMENT ACCEPTED
Friday, May 2, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 2, 2025NON-FINAL ACTION WRITTEN
Friday, May 2, 2025NON-FINAL ACTION E-MAILED
Tuesday, May 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 3, 2025TEAS AMENDMENT OF USE RECEIVED
Thursday, April 3, 2025USE AMENDMENT FILED
Thursday, April 3, 2025AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, May 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 27, 2025APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, May 6, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

corelease veterinary preparations supplement nutritional manufacture pharmaceutical excipients